Ultimately, DRP1 overexpression was observed to positively correlate with cancer cell proliferation and survival in different conditions of metabolic stress, such as oxidative stress and hypoxia; moreover, high DRP1 expression levels in patients with CRPC were found to be suggestive of poor prognosis [171]. This evidence concerns the gene DNM1L and cancer.